# Replimune Group, Inc.: Form 8-K, filed Jan 31, 2022

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2022-01-31
- Accepted by EDGAR: Jan 31, 2022, 16:15 ET
- Period: 2022-01-26
- Accession: 0001104659-22-009561
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465922009561/tm224909d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465922009561/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465922009561/tm224909d1_8k.htm

Filed Jan 31, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-009561. Last ingested by Listed: Nov 7, 2026, 12:41 ET. No prices; not investment advice.